NA
Nautilus Biotechnolgy, Inc.
NAUT · NASDAQ
$1.02 +2.05% (+$0.02)
1M +15.84%
Market Cap $125.9M
P/E Ratio -
Div. Yield -
ROE 37.58%
Bulios Fair Price
$0.88
13.7% downside
Trenutna cena
$1.02
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica NAUT trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
50 /100
Fair P/S 662.80x
P/B 0.96x
P/E N/A
Growth
0 /100
Declining Book val. growth 20.71%
EPS growth N/A
Rev. growth N/A
Profitability
0 /100
Weak Gross margin 919.47%
Net margin 29,747.90%
Op. margin 33,043.70%
Quality
0 /100
Poor ROIC 39.50%
ROE 37.58%
ROA 34.55%
Debt
100 /100
Low Debt/Equity 0.21x
Current ratio 10.14x
Int. coverage N/A
Stability
79 /100
Stable Beta 0.87x
EPS volatility 15.26%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NAUT
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Sujal Patel
Employees
127
Headquarters
Seattle
Prihajajoči dogodki
27 OKT.
Earnings
Upcoming earnings report